HHSN26100043: Leidos Biomedical Research Inc · FederalPipeline
HHSN26100043: Leidos Biomedical Research Inc
Delivery Order to Leidos Biomedical Research Inc by National Institutes of Health: $43.1M obligated, latest action 2022-03-14. Igf::ot::igf Ebola Virus…